RNA Target for Neurodegeneration (G106481539)

Target Name: RNU6-1139P

NCBI ID: G106481539

Other Name(s): RNA, U6 small nuclear 1139, pseudogene

RNA Target for Neurodegeneration

RNA, U6 small nuclear 1139, pseudogene (R Nu6-1139P) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is a 24.8 kilobase (kb) RNA molecule that is expressed in the brain and other tissues.

The RNA molecule is composed of 1139 nontranscribing regions (NTRs) and is located on the 6th chromosome, specifically at position 1139 on the reference transcript. It is a pseudogene, which means that it is a non-coding RNA molecule that has the potential to encode a protein.

R Nu6-1139P has been shown to play a role in various cellular processes, including cell growth, differentiation, and neurotransmission. It has also been linked to various neurological disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

One of the most promising aspects of R Nu6-1139P is its potential as a drug target. By targeting this molecule, researchers and pharmaceutical companies may be able to develop new treatments for a variety of neurological disorders.

In addition to its potential as a drug target, R Nu6-1139P also has the potential as a biomarker. By analyzing the expression levels of this molecule in brain tissue, researchers may be able to identify early signs of neurodegeneration and diagnose neuropsychiatric disorders at an early stage.

Overall, R Nu6-1139P is a promising molecule for research and potential drug development. As more research is conducted on this molecule, it is likely to emerge as a key player in the field of neuroscience and may help to lead to new treatments for a variety of neurological disorders.

Protein Name: RNA, U6 Small Nuclear 1139, Pseudogene

More Common Targets